We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

European Medicines Agency Gives First Opinion for a Vaccine for Use Outside the EU

News   Jun 25, 2012

 
European Medicines Agency Gives First Opinion for a Vaccine for Use Outside the EU
 
 
Advertisement
 

RELATED ARTICLES

Phase 1 Clinical Trial of University of Queensland COVID-19 Vaccine Begins

News

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

READ MORE

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

Common Flu Subtype Is Escaping the Immune Response With Help From a Fast-spreading Mutation

News

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein. This highlights the need for flu vaccines to target multiple sites.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE